Cameron Turtle, CEO: Spyre Therapeutics SYRE Planned sale · Filed 10/01

Trade details

Type: Planned sale notice
Stock: Spyre Therapeutics SYRE
Person: Cameron TurtleCEO
Planned sale date: 26/10/01
Filed: 26/10/01

More to sell after $2.7M in 3 months

Spyre Therapeutics trades, last 26 weeks

What else happened in Spyre Therapeutics around then

Filed or reported within 30 days of the trade day · 09/01~10/31

Cameron Turtle's recent trades

Cameron TurtleCEO
Planned sale10b5-1 planSpyre Therapeutics
Planned sale10b5-1 plan
Spyre Therapeutics
SYRE
$4M
45,000 sh
$4M
Filed 07/01
Traded 07/01
Cameron TurtleCEO
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 plan
Spyre Therapeutics
SYRE
$574.5K
8,149 sh
$574.5K
Filed 06/03
Traded 06/01
Cameron TurtleCEO
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 plan
Spyre Therapeutics
SYRE
$246.9K
3,557 sh
$246.9K
Filed 06/03
Traded 06/01
Cameron TurtleCEO
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 plan
Spyre Therapeutics
SYRE
$235.1K
3,294 sh
$235.1K
Filed 06/03
Traded 06/01
Cameron TurtleCEO
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 plan
Spyre Therapeutics
SYRE
$368.6K
5,300 sh
$368.6K
Filed 05/01
Traded 05/01